Sign Up to like & get
recommendations!
0
Published in 2019 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2019.00304
Abstract: IPO-38 is a potential biomarker for early diagnosis of gastric cancer that we recently identified. Although we characterized its chemical nature as a nucleosome histone, we suspected the existence of histone modification for the IPO-38…
read more here.
Keywords:
antibody labeled;
ipo antibody;
histone;
modification histone ... See more keywords